Roger E. Susi sold $691k of IRMD
CEO, President, Chairman at IRADIMED CORP. 7,500 shares at an average of $92.14, traded May 26, 2026, filed May 28, 2026.
Score components
- +25RoleCEO
- +21Trade size$691k at market
- 0Share of holdings soldSold 0.3% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001613801-26-000041, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 26, 2026 | SOpen-market sale Common Stockindirect: By Phillip Susi 2008 Dynasty Trust10b5-1 | -3,111 | $91.81 | $286k | 2,169,389 | May 28, 2026 |
| May 26, 2026 | SOpen-market sale Common Stockindirect: By Phillip Susi 2008 Dynasty Trust10b5-1 | -1,889 | $92.93 | $176k | 2,167,500 | May 28, 2026 |
| May 27, 2026 | SOpen-market sale Common Stockindirect: By Phillip Susi 2008 Dynasty Trust10b5-1 | -2,167 | $91.85 | $199k | 2,165,333 | May 28, 2026 |
| May 27, 2026 | SOpen-market sale Common Stockindirect: By Phillip Susi 2008 Dynasty Trust10b5-1 | -333 | $92.61 | $31k | 2,165,000 | May 28, 2026 |
Related signals
Other insiders at IRADIMED CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | IRMDsell IRADIMED CORP | Monty K Allen director | $123k 1,419 shares | -7% | |
| 47Moderate | IRADIMED CORP | Hilda Frederique Scharen-Guivel director | $285k 3,000 shares | -35% | |
| 26Weak | IRADIMED CORP | Roger E. Susi CEO, President, Chairman | $227k 2,500 shares | -0% | |
| 25Weak | IRADIMED CORP | Roger E. Susi CEO, President, Chairman | $657k 7,500 shares | -0% | |
| 25Weak | IRADIMED CORP | Roger E. Susi CEO, President, Chairman | $631k 7,500 shares | -0% | |
| 25Weak | IRADIMED CORP | Roger E. Susi CEO, President, Chairman | $643k 7,500 shares | -0% | |
| 25Weak | IRADIMED CORP | Roger E. Susi CEO, President, Chairman | $658k 7,500 shares | -0% | |
| 26Weak | IRADIMED CORP | Roger E. Susi CEO, President, Chairman | $694k 7,500 shares | -0% | |
| 26Weak | IRADIMED CORP | Roger E. Susi CEO, President, Chairman | $697k 7,500 shares | -0% | |
| 26Weak | IRADIMED CORP | Roger E. Susi CEO, President, Chairman | $717k 7,500 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.